Latest news
One in four Americans have exaggerated or made up symptoms to try to get antibiotics
More than a quarter of Americans have exaggerated or made up symptoms to try to get antibiotics from their doctor, either for themselves or for their children, a new study has found.
Apilimod blocks hepatitis E virus entry by targeting PIKfyve
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis, yet antiviral treatment remains largely limited to the off-label use of ribavirin. Seeking alternative treatments,scientists screened compounds that interfere with endocytic and endolysosomal pathways—the intracellular transport system used by HEV during cell entry.
HPV-driven cell death pathways offer new directions for cervical cancer treatment
A new review proposes that PCD in cervical cancer should be understood not as a series of isolated pathways, but as an interconnected regulatory network that governs both tumor behavior and therapeutic sensitivity.
Deep-sea corals in fossil fuel-producing region have distinct microbial communities
Researchers who carried out the first comprehensive study of the microbial communities living in symbiosis with deep-sea corals in one of Brazil’s most active oil- and gas-producing regions discovered that each species hosts a distinct, and sometimes highly specialised, community of microorganisms.
Measles outbreak shows how immunity gaps can unravel disease elimination
A year-long measles outbreak in Ontario was concentrated in closely connected, historically under-vaccinated communities and contributed to Canada losing its measles elimination status. Researchers warn that immunity gaps, cross-border social networks and declining trust in vaccination can quickly undermine decades of disease control.
Study shows how pre-existing immunity shapes second dengue infections
Why can a second dengue infection be more dangerous than the first? A controlled human challenge study shows how pre-existing antibodies can either boost viral replication or help restrain it, offering new clues for designing vaccines that protect against all four dengue virus types.
One in four Americans have exaggerated or made up symptoms to try to get antibiotics
More than a quarter of Americans have exaggerated or made up symptoms to try to get antibiotics from their doctor, either for themselves or for their children, a new study has found.
Apilimod blocks hepatitis E virus entry by targeting PIKfyve
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis, yet antiviral treatment remains largely limited to the off-label use of ribavirin. Seeking alternative treatments,scientists screened compounds that interfere with endocytic and endolysosomal pathways—the intracellular transport system used by HEV during cell entry.
HPV-driven cell death pathways offer new directions for cervical cancer treatment
A new review proposes that PCD in cervical cancer should be understood not as a series of isolated pathways, but as an interconnected regulatory network that governs both tumor behavior and therapeutic sensitivity.
Perpetual Next signs agreement to accelerate the roll-out of standardized biomethanol plants
Perpetual Next have signed a License and Engineering Agreement with Air Liquide Engineering and Technologies for the supply of syngas-to-methanol technology for Perpetual Next’s first biomethanol facility, with an option to extend across other biomethanol sites.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Electricity-powered yeast converts CO₂ into useful chemicals
Researchers have developed an electrobioreactor that turns carbon dioxide into itaconic acid, a valuable chemical used in plastics, textiles and resins. The system combines electrochemistry with engineered yeast, offering a potential route to produce bio-based chemicals from emissions instead of sugar.
Two-in-one tool tracks viral RNA inside live infected cells in real time
The tool lets researchers film activity of Zika and chikungunya viruses in high resolution and identify virus-host interactions, a key step to developing effective antiviral strategies that could stop infections
Light-powered algae bring a soft robotic arm to life
A soft robotic arm powered by living algae can bend, grasp and lift small objects using only changes in light. The device turns photosynthesis-driven changes in acidity into mechanical motion, offering a glimpse of soft robots that could respond to their environment with very little external energy.
Why do some people spread the flu while others avoid infection? Mizzou researchers investigate
Why do some people spread influenza efficiently while others barely pass it on? A new $19 million NIH-funded research programme will investigate how immunity, temperature and humidity shape airborne flu transmission, with the aim of improving vaccines and other prevention strategies.
$16.4m NIH grant launches new hepatitis C vaccine centre
Hepatitis C has long frustrated vaccine developers with its extraordinary ability to mutate and evade immunity. A new $16.4 million research centre will bring together experts in antibodies, T cells and vaccine design to identify the virus’s most stable weak points and develop broadly protective vaccine candidates.
Horizon Awards 2026: Professor Marciane Magnani named as winner of Basil Jarvis Prize
Professor Marciane Magnani, Professor of Food Science at the Federal University of Paraíba (UFPB), Brazil, has been named as the winner of the Basil Jarvis Food Security & Innovation Award.